MAHA ELEVATE Grant Submission Status Audit - 11 Days Before Deadline
Source type:
obs· Harvested: 2026-05-04 · Original date: 2026-05-04T09:37:39.893Z Metadata:{"project":"maha-elevate-2027","type":"discovery","obs_id":65513}
obs/65513 · discovery · 2026-05-04T09:37:39.893Z
MAHA ELEVATE Grant Submission Status Audit - 11 Days Before Deadline
The primary session loaded the MAHA skill and conducted a comprehensive status audit of the CMS MAHA ELEVATE cooperative agreement submission (CMS-2W2-27-001, opportunity number for whole-person functional/lifestyle medicine interventions). With 11 days remaining until the 2026-05-15 deadline, the audit used grep pattern matching to identify all TBD/PENDING/XXX markers and critical institutional identifiers across the entire repository.
The project is the ACES Trial: a pragmatic cluster-randomized evaluation of integrative multi-domain care for N=500 Original Medicare FFS beneficiaries aged 65+ with cardiometabolic or chronic-pain conditions. Maximum award is $3.3M over 36 months structured as two 18-month budget periods.
Critical blockers identified: (1) Applicant legal entity undecided - affects SF-424 line 1, all budget narratives, and SAM.gov registration finalization; (2) Zero executed MOUs despite narrative describing 8 clinics across 3 health systems plus DCC operator; CBWCHC support letter is not an executed MOU and contains possible organization name typo; (3) DCC operator undefined - blocks randomization protocol, biostatistics subaward, and Template 2/3 scoring; (4) SAM.gov/UEI/EIN registration incomplete - UEI expected by approximately 2026-05-11 based on Day 5-15 processing window from 2026-04-26 submission; (5) AOR not designated - blocks SF-424 and SF-LLL signature authority; (6) IRB-of-record not selected despite single-IRB requirement under Common Rule; (7) CHPL/CEHRT product IDs all pending in Table J despite being scored criterion.
Submission package completeness is advanced in technical outputs: 43 peer-reviewed evidence PDFs collected, Tables G/H/I/J generated and PDF-validated (unencrypted, correct page sizes), organizational chart finalized, business assessment at v6, project narrative at v5.2 (15-page limit compliant), budget narrative at v4. The budget elects 10% de minimis indirect cost rate under 2 CFR 200.414(f) because Yang Institute is a new SAM.gov registrant without existing federally negotiated NICRA.
The skill defines a source hierarchy: system/user instructions override repo SOT which overrides official CMS sources which override skill configuration. Current repo is /Users/lunhsiangyuan/Projects/maha-elevate-2027 with shadow workspace at Desktop/maha-elevate-2027. The skill enforces separation of NOFO hard requirements from strategic recommendations and includes auto-update protocol requiring verification of CMS/Grants.gov sources if older than 7 days.
Concepts: [“problem-solution”,“what-changed”,“gotcha”,“how-it-works”]
Facts: [“MAHA ELEVATE CMS-2W2-27-001 submission deadline is 2026-05-15 23:59 ET, current date is 2026-05-04 (11 days remaining)”,“Applicant legal entity remains unresolved between three candidate structures: Yang Institute of Integrative Medicine P.C., Northern Medical Center as prime, or consortium with DCC operator”,“Zero executed MOUs exist; only one support letter from CBWCHC received 2026-05-04, which contains potential typo “CMS MAHC ELEVATE” instead of “CMS MAHA ELEVATE"",“Critical identifiers pending: UEI expected Day 5-15 after 2026-04-26 SAM.gov submission, EIN requires Cynthia disclosure, AOR not designated”,“DCC operator undefined across all budget and narrative documents despite being critical path dependency for cluster randomization”,“IRB-of-record not selected; CHPL Product Numbers all marked PENDING in Table J”,“Submission package inventory complete: 43 evidence PDFs present, Tables G/H/I/J generated, org chart ready, business assessment at v6, project narrative at v5.2”,“Budget structure uses 10% de minimis indirect cost rate due to new SAM.gov registrant status without existing NICRA”]
[← 回 Alfred Brain Hub]